Science
Israeli’s anti-virus spray to begin UK clinical trials this week – Jewish News
SaNOtize Nitric Oxide Nasal Spray, developed by a firm co-founded by Israeli Gilly Regev, is believed to kill up to 99.9% of the coronavirus that causes Covid-19….
The first UK clinical trials of a nasal spray developed by a company co-founded by an Israeli that kills 99.9% of the coronavirus that causes Covid-19, begins this week.
The SaNOtize Nitric Oxide Nasal Spray (NONS) is designed to kill the virus in the upper airways, preventing it from incubating and spreading to the lungs.
The treatment, developed by SaNOtize Research and Development Corp. based in Vancouver, Canada, co-founded by Israeli Gilly Regev, proved 99.9% effective in killing the coronavirus…
-
Business16 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General23 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News15 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News13 hours agoTips to improve engagement – Proctor